Rachel Weiszer

Rachel Weiszer serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirement validation and market research through solicitation, evaluation, award, and contract administration. She plays a critical role in ensuring compliance with the Federal Acquisition Regulation (FAR) and advancing the agency’s mission through strategic sourcing practices. Her portfolio is exclusively focused on medicinal and botanical manufacturing, encompassing the procurement of pharmaceutical ingredients, botanical extracts, and related production systems. She works closely with technical stakeholders to define performance-based requirements and ensures acquisitions align with scientific and regulatory standards in the pharmaceutical supply chain. While specific contractor names are not available, Rachel consistently engages with a diverse pool of vendors specializing in pharmaceutical manufacturing, including small businesses with expertise in natural product extraction, cGMP-compliant production, and sterile processing. Her contracting patterns reflect a preference for collaborative, long-term vendor partnerships that prioritize quality assurance, supply chain resilience, and regulatory adherence. She frequently utilizes performance incentives and contract modifications to drive innovation and compliance. Rachel demonstrates an unwavering commitment to small business participation, with 100% of her acquisitions structured as total small business set-asides under FAR 19.5. She actively promotes equitable access to federal contracting opportunities for small businesses, ensuring that socioeconomic programs such as HUBZone, SDVOSB, and WOSB are fully leveraged where applicable. Her procurement approach emphasizes transparency, fair competition, and meaningful small business development. Her primary NAICS code focus—325411 (Medicinal and Botanical Manufacturing)—reflects deep technical expertise in pharmaceutical production, including active pharmaceutical ingredient synthesis, herbal formulation, and quality control systems. She specializes in procuring complex, regulated goods requiring stringent documentation, FDA alignment, and GMP compliance, positioning her as a key player in the nation’s secure and sustainable medicinal supply chain.